Page 25 - 南京医科大学自然版

第46卷第6期 孙 庆，梁 迪，何 健. 肝转移瘤 F⁃FDG PET/CT研究进展与展望［J］.
18
2026年6月 南京医科大学学报（自然科学版），2026，46（6）：799-808 ·807 ·

18
tumor volume from F⁃FDG PET/CT in combination with ses［J］. Nucl Med Commun，2023，44（5）：381-389
radiologic measurements to predict long⁃term survival fol⁃ ［41］HAZHIRKARZAR B，KHOSHPOURI P，SHAGHAGHI
lowing transplantation for colorectal liver metastases［J］. M，et al. Current state of the art imaging approaches for
Cancers，2024，16（1）：19 colorectal liver metastasis［J］. Hepatobiliary Surg Nutr，
［30］STERN N M，MIKALSEN L T G，DUELAND S，et al. The 2020，9（1）：35-48
18
prognostic value of F FDG PET/CT texture analysis prior ［42］LUND M，BJERRE T A，GRØNBÆK H，et al. CEUS com⁃
to transplantation for unresectable colorectal liver metas⁃ pared with CECT，MRI，and FDG⁃PET/CT for diagnosing
tases［J］. Clin Physiol Funct Imaging，2025，45（1）： CRC liver metastases：a diagnostic test accuracy systemat⁃
e12908 ic review and meta⁃analysis［J］. Expert Rev Gastroenterol
［31］DEL CARPIO L P，ALGARRA M A，SABATÉ⁃LLOBERA Hepatol，2024，18（9）：541-549
A，et al. Differences in glucose metabolic activity in liver ［43］TAHTABASI M，ERTURK S M，BASAK M. Comparison
18
metastasis separates two groups of metastatic uveal mela⁃ of MRI and F ⁃ FDG PET/CT in the liver metastases of
noma patients with different prognosis［J］. Cancer Med， gastrointestinal and pancreaticobiliary tumors［J］. Sisli Et⁃
2023，12（13）：14062-14071 fal Hastan Tip Bul，2021，55（1）：12-17
［32］INOUE D，OURA S. Eosinophilic variant of chromophobe ［44］OH J W，OH S N，CHOI J I，et al. Does the gadoxetic acid⁃
renal cell carcinoma metastasizing to the liver：diagnostic enhanced liver MRI impact on the treatment of patients
18
pitfall［J］. Radiol Case Rep，2023，18（10）：3504-3508 with colorectal cancer? Comparison study with F ⁃ FDG
［33］HWANG J Y，LEE J E，JUNG M J. A challenging case of PET/CT［J］. Biomed Res Int，2016，2016：8412071
solitary necrotic nodules of the liver mimicking hepatic ［45］FÜLÖP A C，SERAC G，GURZU S. Detection of hepatic
metastases：CT，MRI，and PET ⁃ CT findings［J］. J Belg metastasis in colorectal cancer：a comparative case report
18
Soc Radiol，2020，104（1）：16 of F⁃FDG PET⁃CT and diffusion⁃weighted MRI with a b
18
［34］LYU Q H，LIN D Y，TANG M D，et al. F⁃FDG PET/CT value of 1000［J］. J Belg Soc Radiol，2023，107（1）：52
18
and MR imaging features of liver metastases in gastroin⁃ ［46］SHI Y G，YU H X，ZHANG X Y，et al. F⁃FDG PET/CT
18
testinal stromal tumors：a cross ⁃ sectional analysis［J］. versus F⁃FDG PET/MRI in the evaluation of liver metas⁃
Ann Transl Med，2022，10（22）：1220 tasis in patients with primary cancer：a head⁃to⁃head com⁃
［35］BORELLO A，RUSSOLILLO N，LO TESORIERE R，et al. parative meta ⁃ analysis［J］. Clin Imaging，2024，112：
Diagnostic performance of the FDG ⁃ PET/CT in patients 110209
with resected mucinous colorectal liver metastases［J］. ［47］BEIDERWELLEN K，GERALDO L，RUHLMANN V，et
18
Surgeon，2021，19（5）：e140-e145 al. Accuracy of F FDG PET/MRI for the detection of
［36］TSURUSAKI M，OKADA M，KURODA H，et al. Clinical liver metastases［J］. PLoS One，2015，10（9）：e0137285
18
application of F⁃fluorodeoxyglucose positron emission to⁃ ［48］SINGNURKAR A，POON R，METSER U. Head⁃to⁃head
mography for assessment and evaluation after therapy for comparison of the diagnostic performance of FDG PET/CT
malignant hepatic tumor［J］. J Gastroenterol，2014，49 and FDG PET/MRI in patients with cancer：a systematic
（1）：46-56 review and meta ⁃ analysis［J］. AJR Am J Roentgenol，
［37］AYAZ U Y，AYAZ S. SUVmax⁃to⁃HU ratio in diagnosis 2024，223（3）：e2431519
of hepatic metastases of colon cancer on FDG PET/CT. A ［49］COHEN D，KESLER M，MUCHNIK KURASH M，et al. A
new semiquantitative parameter［J］. Ann Ital Chir，2023， lesson in humility：the added values of PET⁃MRI over PET⁃
94：27-35 CT in detecting malignant hepatic lesions［J］. Eur J Nucl
［38］CHICKLORE S，GOH V，SIDDIQUE M，et al. Quantifying Med Mol Imaging，2023，50（5）：1423-1433
18
tumour heterogeneity in F⁃FDG PET/CT imaging by tex⁃ ［50］AKKUS GUNDUZ P，OZKAN E，KURU OZ D，et al. Clini⁃
ture analysis［J］. Eur J Nucl Med Mol Imaging，2013，40 cal value of fluorine⁃18⁃fluorodeoxyglucose PET/MRI for
（1）：133-140 liver metastasis in colorectal cancer ：a prospective
［39］HARTMANN L，BUNDSCHUH L，ZSÓTÉR N，et al. Tu⁃ study［J］. Nucl Med Commun，2023，44（2）：150-160
mor heterogeneity for differentiation between liver tumors ［51］ZHOU N N，MENG X X，ZHANG Y，et al. Diagnostic value
18
and normal liver tissue in F⁃FDG PET/CT［J］. Nuklear⁃ of delayed PET/MR in liver metastasis in comparison with
medizin，2021，60（1）：25-32 PET/CT［J］. Front Oncol，2021，11：717687
［40］MISHRA A，RAVINA M，KOTE R，et al. Role of textural ［52］CHENG G，TORIGIAN D A，ZHUANG H M，et al. When
analysis parameters derived from FDG PET/CT in differ⁃ should we recommend use of dual time⁃point and delayed
entiating hepatocellular carcinoma and hepatic metasta⁃ time ⁃ point imaging techniques in FDG PET?［J］. Eur J